A DOUBLE-BLIND, PLACEBO-CONTROLLED, STUDY TO EVALUATE THE EFFICACY AND SAFETY OF 24 WEEKS TREATMENT WITH REN001 IN PATIENTS WITH PRIMARY MITOCHONDRIAL MYOPATHY (PMM)

Project: Research

Project Details

StatusFinished
Effective start/end date4/10/21 → 31/12/24

Keywords

  • Primary mitochondrial myopathy
  • Mitochondrial disease
  • Neurology
  • Clinical trial